IntroductionThis article will explain how a sales manager can approach ethical issues in a socially responsible manner. To accomplish this, current ethical issues related to sales management, both overseas and domestic, will be addressed within the framework of a U.S.-based organization. Analogies and experiments will also be discussed regarding the study results. Furthermore, the relevance of these results to the argument made regarding resolving the problem of ethical issues will be revealed. Additionally, recommendations will be made on how sales managers can approach ethical issues. Current ethical issues related to sales management, both overseas and domestic. Current ethical issues related to sales management include topics such as unethical behaviors of salespeople in a domestic and foreign environment. . These include situations relating to the pharmaceutical industry, as well as other related industries, including incurring marketing/sales related expenses that are considered to exceed modest expenses. The problem is that these expenses will be passed on to the end consumer in the form of more expensive products, such as pharmaceutical and medical products for example. Other issues include using high-pressure sales tactics to coerce customers into short-term purchases of products that may not meet their needs and result in lost sales in the long term. Additionally, unethical behavior can also include salespeople being forced to provide free items to customers, which is likely a particularly serious problem related to sales representatives selling diagnostic tools. Another issue regarding ethics is that of fair evaluation of s...... middle of paper ...... even without spending money on additional marketing and promotion programs. In other words, companies that cannot spend a lot of money on promotions in the Turkish market can still compete to some extent by ensuring that their sellers meet these criteria. Many sales representatives, however, have reported using free medical items as a negotiating tool to get doctors to prescribe brand-name pharmaceuticals rather than generics in a high percentage of cases (Tengilimoglu et al., 2004). These questions, once again, pose great concerns for sales managers in the pharmaceutical industry who must manage a national sales force with all the new guidelines in effect in the United States, as well as managers who must manage salespeople on the global market with the threat of these new guidelines and the need to self-regulate to some extent simply because of the threat.